NEWS COMMENTARY

Not all 3D printing companies are chasing the SPAC craze – Formlabs raises $150 million Series E from SoftBank

Published:
May 27, 2021
Last Updated:
May 27, 2021
Services:
Chemicals More...
Priorities:
Materials Needs Discovery More...
Activities:
Investment
Very important

With the IPOs of Desktop Metal, Markforged, Shapeways, Rocket Labs, Velo3D, Rokit, Massvit 3D, and MeaTech 3D, SPAC seems to have become the new norm in the 3DP space. As we said before, the SPAC craze creates much noise in the market, and not all of these companies should go public – some do so simply because they can't raise enough money from private investors. Formlabs, which has consistently rolled out new products with more than $100 million annual revenue, has proven again that its sustainable business model is appreciated by private investors. Clients should expect more product updates from the company, but an IPO is not on the horizon, though Carbon may go public this year.

For the original news article, click here .


Further Reading

Desktop Metal acquires Aerosint, its fourth acquisition in 2021

News Commentary | July 13, 2021

Desktop Metal (DM) announced the Aerosint acquisition shortly after acquiring EnvisionTEC, Adaptive3D, and Forust. Lux Research has expected this move from DM, as it has been aggressively expanding its product portfolio. It continues to burn all its SPAC funding on acquisitions rather than focusing ... Not part of subscription

Essentium acquires Collider, which was looking for an exit since 2019

News Commentary | August 12, 2021

The 3D printing space is seeing a lot of activity around mergers and acquisitions this year, and most companies are looking to expand their product portfolio rather than focusing on strengthening their core technology. Essentium's acquisition of Collider is similar, as this is the company's entrance... Not part of subscription

Apeel raises $250 million Series E, bringing its valuation to more than $2 billion

News Commentary | August 19, 2021

Led by Temasek, this Series E funding round also had other prominent investors and brings Apeel's total funding to $635 million. This latest investment will allow Apeel to expand its supply chain reach and develop its recent technology acquisition based on hyperspectral imaging. Apeel's glycerolipid... Not part of subscription